Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

RXi Pharmaceuticals Corporation (RXII) - Financial Analysis Review

RXi Pharmaceuticals Corporation (RXII) - Financial Analysis Review Summary RXi Pharmaceuticals Corporation (RXi) is a b...

07 Jan 2014 GlobalData 33 $125.00

RXi Pharmaceuticals Corporation (RXII) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

RXi Pharmaceuticals Corporation (RXII) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary RXi Pharmaceutica...

13 Dec 2013 GlobalData 19 $250.00

RXi Pharmaceuticals Corp.: Low-Hanging Fruit in the RNAi Space

The following is an excerpt from the Streetwise Reports interview with Reni "Ren" Benjamin, Managing Director and Equity Rese...

12 Dec 2013 Streetwise Reports 2 $12.00

RXi Pharmaceuticals Corp.: An Innovative Approach to RNA Molecule Delivery

The following is an excerpt from the Streetwise Reports interview with Dr. Craig C. Mello, professor at the University of Mas...

21 Nov 2013 Streetwise Reports 2 $12.00

The Stunning Potential of Gene Silencing: Nobel Laureate Craig C. Mello

The era of gene regulation has begun in earnest. Craig Mello and Andrew Fire won the Nobel Prize in Physiology or Medicine in...

21 Nov 2013 Streetwise Reports 8 $81.00

RXi Pharmaceuticals Corporation (RXII) - Financial Analysis Review

RXi Pharmaceuticals Corporation (RXII) - Financial Analysis Review Summary RXi Pharmaceuticals Corporation (RXi Pharmaceutica...

17 Oct 2013 GlobalData 32 $125.00

RXi Pharmaceuticals Corporation (RXII) - Financial Analysis Review

RXi Pharmaceuticals Corporation (RXII) - Financial Analysis Review Summary RXi Pharmaceuticals Corporation (RXi Pharmaceutica...

17 Sep 2013 GlobalData 32 $125.00

RXi Pharmaceuticals Corp.: Data/Results Should Lead to a Prolonged Uptick

The following is an excerpt from the Streetwise Reports interview with Keith Markey, science director for Griffin Securities ...

12 Sep 2013 Streetwise Reports 2 $12.00

Griffin Securities' Keith Markey Gives Performance Reviews on Four Favorite Biotech Names

As science director for Griffin Securities, Keith Markey knows his way around the advanced technologies of the most promising...

12 Sep 2013 Streetwise Reports 5 $46.00

RXIID - RXi Pharmaceuticals Corp - Rated a Hold - Company Analysis and ASR Ranking Report

www.AlphaStreetResearch.com - Full Coverage of 3,000 U.S. equities. Reports include Financials, Ratios, Competitor Comparison...

22 Aug 2013 Alpha Street Research 9 $24.00